PedAM
Pediatric Disease Annotations & Medicines
| Disease | dystonia |
| Phenotype | C0005747|blepharospasm |
| Sentences | 10 |
| PubMedID- 20507022 | Orbicularis oculi myo-osseous fixation: a new treatment for benign essential blepharospasm and blepharospasm associated with diffuse facial dystonia (meige syndrome). |
| PubMedID- 26056611 | Marginally significantly different from dystonia cases with blepharospasm (p <0.10, mann–whitney test). |
| PubMedID- 24131497 | Exclusion criteria were as follows: presence of any multifocal dystonia with blepharospasm or oromandibular manifestations, a positive family history for dystonia and a history of any other neurological disease or relevant vascular diseases. |
| PubMedID- 24868394 | blepharospasm is a form of focal dystonia characterized by involuntary spasms of orbicularis oculi muscles. |
| PubMedID- 23210426 | blepharospasm is a form of focal dystonia characterized by involuntary closure of the eyelids, more common in women [1]. |
| PubMedID- 25764999 | The spread of dystonia in patients with the initial blepharospasm was faster, while patients with the writer's cramp could expect further progression even after longer periods of time. |
| PubMedID- 20616916 | Meige syndrome is a cranial dystonia with bilateral blepharospasm accompanied by dystonia in the lower face. |
| PubMedID- 25992183 | The food and drug administration first approved botulinum toxin (bt) type a in 1989 for the treatment of strabismus and blepharospasm associated with dystonia in patients 12 years of age or older. |
| PubMedID- 23747003 | Background: blepharospasm is a form of focal dystonia that manifests as repetitive involuntary closure of the eyes. |
| PubMedID- 25657764 | Neurologic manifestations include orofacial dystonia with blepharospasm and grimacing, dysarthria, chorea, tremor and gait ataxia (25). |
Page: 1